寨卡病毒包膜蛋白结构域III免疫可诱导针对寨卡病毒的特异性中和免疫应答
本研究将寨卡病毒包膜蛋白结构域III(zEDIII)在大肠杆菌中快速表达并纯化至>95%纯度,以25和50μg皮下免疫小鼠11周。zEDIII可诱导寨卡病毒特异性中和抗体,滴度超过与保护性免疫相关的阈值;抗原特异性IgG以IgG1为主,脾细胞分泌IFN-γ、IL-4和IL-6;zEDIII诱导的抗体在表达FcγR的细胞中不增强登革病毒感染。
要点
- zEDIII经一步Ni2+亲和层析纯化至>95%纯度,正确折叠并特异性结合构象表位单抗。
- 25和50μg zEDIII皮下免疫小鼠11周,诱导寨卡病毒特异性中和抗体超过保护相关阈值。
- zEDIII诱导的抗体在表达FcγR细胞中不增强登革病毒感染。
核心结论
- 本研究为 further development of recombinant protein-based subunit vaccines against ZIKV 提供了原理验证(proof of principle)。
研究设计与样本
- 研究描述寨卡病毒包膜蛋白结构域III(zEDIII)作为蛋白亚单位疫苗候选的制备与免疫原性。
- zEDIII在大肠杆菌包涵体中快速表达,经溶解、复性和一步Ni2+亲和层析纯化至>95%纯度。
- 小鼠皮下免疫25和50μg zEDIII,持续11周。
主要发现
- zEDIII正确折叠,并特异性结合识别zEDIII构象表位的抗zEDIII单克隆抗体。
- zEDIII诱导寨卡病毒特异性中和抗体应答,滴度超过与抗寨卡病毒保护性免疫相关的阈值。
- 抗原特异性IgG同型以IgG1为主;免疫小鼠脾细胞培养分泌IFN-γ、IL-4和IL-6。
- zEDIII诱导的抗体在表达Fcγ受体(FcγR)的细胞中不增强登革病毒感染。
关键数值与推荐
- zEDIII纯化至>95%同质性。
- 小鼠皮下免疫剂量为25和50μg zEDIII,免疫周期11周。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this study, we described the generation and immunogenicity of the Zika Virus (ZIKV) envelope protein (E) domain III (DIII) as a protein subunit vaccine candidate. ZIKV EDIII (zEDIII) was rapidly produced in E. coli in inclusion bodies. ZIKV EDIII was solubilized, refolded and purified to >95% homogeneity with a one-step Ni2+ affinity chromatography process. Further analysis revealed that zEDIII was refolded properly and demonstrated specific binding to an anti-zEDIII monoclonal antibody that recognizes a zEDIII conformational epitope. Subcutaneous immunization of mice with 25 and 50μg of zEDIII was performed over a period of 11weeks. zEDIII evoked ZIKV-specific and neutralizing antibody response with titers that exceed the threshold that correlates with protective immunity against ZIKV. The antigen-specific IgG isotypes were predominantly IgG1 and splenocyte cultures from immunized mice secreted IFN-gamma, IL-4 and IL-6. Notably, zEDIII-elicited antibodies did not enhance the infection of dengue virus in Fc gamma receptor (FcγR)-expressing cells. This study provided a proof of principle for the further development of recombinant protein-based subunit vaccines against ZIKV.
引用
- Yang M, Dent M, Lai H, et al. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Vaccine. 2017. PMID: 28669618. doi:10.1016/j.vaccine.2017.04.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。